2013
DOI: 10.3109/08982104.2013.805338
|View full text |Cite
|
Sign up to set email alerts
|

Investigation of parameters influencing incorporation, retention and cellular cytotoxicity in liposomal formulations of poorly soluble camptothecin

Abstract: Improving tumor delivery of lipophilic drugs through identifying advanced drug carrier systems with efficient carrier potency is of high importance. We have performed an investigative approach to identify parameters that affect liposomes' ability to effectively deliver lipophilic camptothecin (CPT) to target cells. CPT is a potent anticancer drug, but its undesired physiological properties are impairing its therapeutic use. In this study, we have identified parameters influencing incorporation and retention of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 40 publications
0
1
0
Order By: Relevance
“…This phenomenon may diminish the available number of aromatic sites at which the drug can interact, since the sites are partially covered by FA−PEG molecules. Furthermore, the degree of loading of these nanomaterials was higher than that of other nanocarriers, such as liposomes 55,56 and solid lipid nanoparticles, 57,58 which is a great advantage over conventional nanocarriers because a higher concentration of drugs can be delivered. For liposomes and solid lipid nanoparticles, the drug should be dissolved or added inside a matrix during the drug loading process.…”
Section: Resultsmentioning
confidence: 99%
“…This phenomenon may diminish the available number of aromatic sites at which the drug can interact, since the sites are partially covered by FA−PEG molecules. Furthermore, the degree of loading of these nanomaterials was higher than that of other nanocarriers, such as liposomes 55,56 and solid lipid nanoparticles, 57,58 which is a great advantage over conventional nanocarriers because a higher concentration of drugs can be delivered. For liposomes and solid lipid nanoparticles, the drug should be dissolved or added inside a matrix during the drug loading process.…”
Section: Resultsmentioning
confidence: 99%